Complete response of a metastatic gastroesophageal adenocarcinoma on irinotecan-based chemotherapy in a dialysis patient

We present the first case report of a complete response of metastatic gastroesophageal cancer in a chronic hemodialysis patient with irinotecan-based chemotherapy. An elderly dialysis patient presented with diffuse liver metastases by a gastroesophageal adenocarcinoma. He received combination chemot...

Full description

Bibliographic Details
Main Authors:	Verwimp, J, Geurs, F, Ponette, S, Ponette, J, Martens, J, Bulté, K
Format:	Online
Language:	English
Published:	Dove Medical Press 2010
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108765/

id	pubmed-3108765
recordtype	oai_dc
spelling	pubmed-31087652011-06-21 Complete response of a metastatic gastroesophageal adenocarcinoma on irinotecan-based chemotherapy in a dialysis patient Verwimp, J Geurs, F Ponette, S Ponette, J Martens, J Bulté, K Case Report We present the first case report of a complete response of metastatic gastroesophageal cancer in a chronic hemodialysis patient with irinotecan-based chemotherapy. An elderly dialysis patient presented with diffuse liver metastases by a gastroesophageal adenocarcinoma. He received combination chemotherapy with 5 fluorouracil and irinotecan. After six months of chemotherapy, liver scans show complete remission. The principles, practice, and experience of chemotherapy with irinotecan during dialysis are discussed. Dove Medical Press 2010-05-17 /pmc/articles/PMC3108765/ /pubmed/21694930 Text en © 2010 Verwimp et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
repository_type	Open Access Journal
institution_category	Foreign Institution
institution	US National Center for Biotechnology Information
building	NCBI PubMed
collection	Online Access
language	English
format	Online
author	Verwimp, J Geurs, F Ponette, S Ponette, J Martens, J Bulté, K
spellingShingle	Verwimp, J Geurs, F Ponette, S Ponette, J Martens, J Bulté, K Complete response of a metastatic gastroesophageal adenocarcinoma on irinotecan-based chemotherapy in a dialysis patient
author_facet	Verwimp, J Geurs, F Ponette, S Ponette, J Martens, J Bulté, K
author_sort	Verwimp, J
title	Complete response of a metastatic gastroesophageal adenocarcinoma on irinotecan-based chemotherapy in a dialysis patient
title_short	Complete response of a metastatic gastroesophageal adenocarcinoma on irinotecan-based chemotherapy in a dialysis patient
title_full	Complete response of a metastatic gastroesophageal adenocarcinoma on irinotecan-based chemotherapy in a dialysis patient
title_fullStr	Complete response of a metastatic gastroesophageal adenocarcinoma on irinotecan-based chemotherapy in a dialysis patient
title_full_unstemmed	Complete response of a metastatic gastroesophageal adenocarcinoma on irinotecan-based chemotherapy in a dialysis patient
title_sort	complete response of a metastatic gastroesophageal adenocarcinoma on irinotecan-based chemotherapy in a dialysis patient
description	We present the first case report of a complete response of metastatic gastroesophageal cancer in a chronic hemodialysis patient with irinotecan-based chemotherapy. An elderly dialysis patient presented with diffuse liver metastases by a gastroesophageal adenocarcinoma. He received combination chemotherapy with 5 fluorouracil and irinotecan. After six months of chemotherapy, liver scans show complete remission. The principles, practice, and experience of chemotherapy with irinotecan during dialysis are discussed.
publisher	Dove Medical Press
publishDate	2010
url	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108765/
_version_	1611457762413248512

Complete response of a metastatic gastroesophageal adenocarcinoma on irinotecan-based chemotherapy in a dialysis patient

Similar Items